Expanding global access to radiotherapy has both lifesaving and economic benefits

Over the past years, radiotherapy has become increasingly important and critical in cancer treatment and care. For many of the most common cancers in low-income and middle-income countries, radiotherapy is essential for effective treatment. In high-income countries, radiotherapy is already used in more than half of all cases of cancer. However, radiotherapy is still often the last resource to be considered in planning and building treatment capacity.

AIO-Blauw_4ptsHybrideLongMasker_33775_2MI_12MI_N_ArmenBovenLichaam-700x466

In a study published in the Lancet Oncology, the shortfall in access to radiotherapy by country and globally for 2015-35 based on current and projected needs was determined. The cost and the net benefit of scaling up radiotherapy across all low-income and middle-income countries was calculated using different models. Next to positive economic benefits, investment in radiotherapy is also lifesaving. Scaling up could lead to saving of 26.9 million life-years over the lifetime of patients who receive treatment.

Source

Expanding global access to radiotherapy
Atun, Rifat et al.
The Lancet Oncology , Volume 16 , Issue 10 , 1153 – 1186
http://dx.doi.org/10.1016/S1470-2045(15)00222-3

Subscribe to our mailing list

* indicates required
Select your preferred newsletters

The protection of your personal data is our priority. Thank you for subscribing to one of our newsletters. We would like to invite you to share some personal data with us. The protection of this data is our priority.

By submitting this form, I agree to the processing of my data to receive personal messages by mail.

You can change your mind at any time by clicking the unsubscribe link in the footer of any email you receive from us, or by contacting us at welcome@orfit.com. We will treat your information with respect. For more information about our privacy practices please visit our website. By clicking below, you agree that we may process your information in accordance with these terms.

We use MailChimp as our marketing automation platform. By clicking below to submit this form, you acknowledge that the information you provide will be transferred to MailChimp for processing in accordance with their Privacy Policy and Terms.